Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma.

Gok Yavuz, Betul; Hasanov, Elshad; Lee, Sunyoung S; Mohamed, Yehia I; Curran, Michael A; Koay, Eugene J; Cristini, Vittorio; Kaseb, Ahmed O

Gok Yavuz, Betul; Hasanov, Elshad; Lee, Sunyoung S; Mohamed, Yehia I; Curran, Michael A; Koay, Eugene J; Cristini, Vittorio; Kaseb, Ahmed O.

Afiliación

Gok Yavuz B; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hasanov E; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lee SS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mohamed YI; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Curran MA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Koay EJ; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cristini V; Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX, USA.
Kaseb AO; Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

J Hepatocell Carcinoma ; 8: 1195-1207, 2021.

Article en En | MEDLINE | ID: mdl-34595140

Palabras clave

biomarker; hepatocellular carcinoma; immunotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Hepatocell Carcinoma Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google